Table 3 Performance of the PELOD-2 score according to study days
Day 1 | Day 2 | Day 5 | Day 8 | Day 12 | |
|---|---|---|---|---|---|
Number of patients | 443 | 411 | 295 | 231 | 165 |
Mortality rate | 119 (27 %) | 98 (24 %) | 67 (23 %) | 51 (22 %) | 41 (25 %) |
PELOD-2 (median, IQR) | 7 (5;10) | 7 (5;10) | 7 (4;9) | 6 (3;9) | 6 (3;9) |
AUC (95 % CI) | 0.76 (0.71–0.81) | 0.78 (0.73–0.84) | 0.74 (0.67–0.81) | 0.74 (0.66–0.82) | 0.77 (0.68–0.85) |
Hosmer–Lemeshow test | p = 0.76 | p = 0.63 | p = 0.09 | p = 0.30 | p = 0.77 |